Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Vaccines work well in Netherton syndrome patients, similar to healthy people.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

Icariin can regulate macrophages and may help treat inflammation, cancer, bone disorders, and fibrotic diseases.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

The document lists various dermatology topics, treatments, and diagnostic methods.

Targeting Vδ1+T-cells may help treat alopecia areata.

Baricitinib is effective and safe for treating alopecia areata in Korea.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

NK cells play a role in skin diseases like eczema and psoriasis.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

RANKL causes lymph nodes to grow by making certain cells multiply.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.